Earli

Summary

The company focuses on developing innovative genetic constructs that specifically target cancer cells, enabling them to self-identify and self-destruct. Their approach aims to revolutionize early cancer detection and treatment, making the experience of cancer less severe by catching it at its earliest stages. They collaborate with various partners to enhance their technology and have received significant funding to advance their mission.